Background
==========

*Campylobacter jejuni*is now well established as the leading cause of bacterial food-borne gastroenteritis worldwide \[[@B1],[@B2]\]. Infection symptoms vary in severity and may include nausea, severe or bloody diarrhea, abdominal cramping and fever \[[@B3]\]. *C. jejuni*infection is usually self-limiting, but in some cases may progress to the debilitating, polyneuropathic disorders Guillain-Barré syndrome (GBS) or the oculomotor variant Miller Fisher syndrome (MFS) \[[@B4],[@B5]\]. Importantly, *C. jejuni*is the commonest antecedent infection in these neuropathies and expression of carbohydrate epitopes mimicking host gangliosides is considered a prerequisite for neuropathy development since such mimicry can induce pathogenic, cross-reactive antibodies \[[@B6],[@B7]\]. Gangliosides are glycosphingolipids occurring in high concentration in the peripheral nervous system, particularly in the nerve axon \[[@B8]\]. A humoural response against these glycolipids (*e.g.*anti-GM~1~, GM~1b~, GD~1a~, GalNAc-GD~1a~GT~1a~and GQ~1b~antibodies) plays a central role in GBS and MFS development \[[@B6],[@B7]\]. Mimicry of the saccharide component of gangliosides within the outer core of *C. jejuni*lipooligosaccharides (LOS) is well documented \[[@B9],[@B10]\]. Supporting a pathogenic role of *C. jejuni*in GBS, *C. jejuni*LOS-induced anti-GM~1~ganglioside antibodies react at the nodes of Ranvier, where the axon is exposed in the nerve fibre \[[@B11]\], resembling the pathology observed in GBS patients, and inoculation of *C. jejuni*GM~1~-mimicking LOS has been reported to induce GBS-like symptoms in a rabbit model \[[@B12]\].

*C. jejuni*is capable of growth at temperatures ranging from 30 to 47°C and therefore is capable of growth at the body temperatures of human and avian hosts, 37 and 42°C, respectively \[[@B13],[@B14]\]. Different temperature environments may trigger events to accommodate the colonization, commensalism, pathogenesis or dormancy of this bacterium. Over 350 genes have been reported to be differentially expressed at 37°C compared to 42°C, including the *galE*and *wlaE*genes found in the LOS biosynthesis locus \[[@B15]\]. Moreover, LOS is an important pathogenic factor of *C. jejuni*. Arising from this, it is possible that *C. jejuni*LOS expression is affected by temperature, whether it is by variable gene expression or at the enzymatic activity level. Although mimicry of gangliosides by *C. jejuni*LOS has been extensively studied structurally over the last two decades \[[@B9],[@B10]\], it is important to note that these previous characterization studies have been performed on strains grown at 37°C.

The human isolate *C. jejuni*NCTC 11168 has been a basis for studying this bacterial species since the late 1970s. The sequencing and annotation of its genome was published by the Sanger Centre \[[@B16]\]. A later study revealed that the genome-sequenced strain of *C. jejuni*NCTC 11168 (11168-GS) is a poor colonizer of 1 day-old chicks and showed that this variant had an altered morphology and a different transcriptional profile compared with the original NCTC 11168 isolate (11168-O) \[[@B17]\]. Recurrent passaging of *C. jejuni*11168-O in laboratory conditions was considered responsible for this variation.

To date, a number of genes from the LOS biosynthesis cluster of *C. jejuni*NCTC 11168 (HS:2) have been characterized \[[@B4],[@B18]\] and the structures of the lipid A and saccharide components of the LOS have been reported \[[@B19]-[@B21]\]. The LOS outer core mimics the oligosaccharide (OS) region of GM~1~ganglioside \[[@B20],[@B21]\] and is likely to be capable of switching from a GM~1~-like epitope to a GM~2~-like epitope as a result of phase variation \[[@B22],[@B23]\].

The lack of knowledge of the structure of *C. jejuni*LOS at 42°C compared to 37°C prompted us to examine the effect of incubation temperature on the phenotypic variation of LOS, including the mimicry of gangliosides, in *C. jejuni*11168-GS and 11168-O. Variation in LOS structure was assessed by electrophoretic analysis and immunoblotting and confirmed by nuclear magnetic resonance (NMR) spectroscopy. Carbohydrate epitopes produced by both strains were assessed for ganglioside mimicry using various anti-ganglioside ligands (*i.e.*antibodies, lectins and cholera toxin) as probes. In addition, LOS structural variation at these two incubation temperatures was examined in minimally subcultured *C. jejuni*isolates from humans and chickens. Importantly, notable differences were observed in the relative production by *C. jejuni*of varying size and ganglioside mimicries at 37°C and 42°C.

Results
=======

Electrophoretic analysis of *C. jejuni*LOS preparations
-------------------------------------------------------

Mini-preparations of LOS isolated from *C. jejuni*11168-GS and 11168-O strains grown at 37°C and 42°C were examined using sodium dodecyl suphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The LOS from *C. jejuni*11168-O and 11168-GS strains resolved into two distinct forms, referred to from here on as higher-M~r~and lower-M~r~LOS (Figure [1b](#F1){ref-type="fig"}). Two control LOS with a known size (Figure [1a](#F1){ref-type="fig"}) from *M. catarrhalis*serotype A (strain 2951) were used for relative sizing of *C. jejuni*LOS. The first was wild-type LOS and resolved on the SDS-PAGE with the lower band at \~4 kDa (lane 1). The second was a LOS from a *lgt4*mutant (2951Δ*lgt4*) of *M. catarrhalis*2951, lacking one glucose and resolved at \~3 kDa \[[@B24]\] (lane 2). Therefore, the difference of one hexose unit corresponded to a relative migration of \~1 kDa. Accordingly, these controls were used to compare the sizes of the *C. jejuni*LOS forms (Figure [1b](#F1){ref-type="fig"} and [1c](#F1){ref-type="fig"}). The higher-M~r~form of *C. jejuni*LOS resolved at approximately 6 kDa (and corresponds to the previously described LOS bearing GM~1~mimicry \[[@B20]-[@B23]\]), whereas the lower-M~r~form, which has not been previously reported, was observed at \~4 kDa. Figure [1b](#F1){ref-type="fig"} shows that *C. jejuni*11168-O (lanes 3 and 4) and 11168-GS (lanes 5 and 6) have a greater amount of the 4 kDa LOS form at 42°C, than at 37°C. For both 11168-O and -GS at 42°C the amount of LOS produced appears greater than at 37°C, both in terms of quantity of the 6 kDa form and the 4 kDa form. Densitometry analysis revealed that for 11168-O at 37°C (Figure [1b](#F1){ref-type="fig"}, lane 3) 6.3% of the total LOS produced was the 4 kDa form and 93.7% was the 6 kDa form. In contrast, at 42°C 35.5% of total LOS produced was the 4 kDa form and 64.5% was the 6 kDa form. Similar results were observed for 11168-GS variant. These results were confirmed using purified LOS preparations from *C. jejuni*11168-O and 11168-GS, which gave identical electrophoretic profiles (data not shown) as those of the LOS mini-preparations. Also, the total amount of protein isolated from the same cell populations of *C. jejuni*11168-O and *C. jejuni*11168-GS were unaffected by the change of growth temperature (data not shown), thus allowing normalisation of cell samples prior to proteinase K digestion to produce LOS mini-preparations for comparison. In contrast to LOS, the CPS profiles from the same populations were unaffected by change of growth temperature (data not shown).

![**Silver-stained SDS-PAGE gel of the LOS extracted from *C. jejuni*NCTC 11168 and 520**. (a) Controls of *M. catarrhalis*serotype A (strain 2951) LOS for relative sizing LOS. Lanes: 1, *M. catarrhalis*wild-type LOS (WT); 2, *M. catarrhalis*M¯mutant LOS lacking the terminal glucose; (b) *C. jejuni*11168-O and 11168-GS LOS extracted from bacteria grown at 37°C and 42°C. Lanes: 3, 11168-O at 37°C; 4, 11168-O at 42°C; 5, 11168-GS at 37°C; 6, 11168-GS at 42°C. (b) *C. jejuni*520 LOS extracts from bacteria grown at 37°C and 42°C. Lanes: 1, 520 at 37°C; 2, 520 at 42°C. Higher-M~r~LOS resolved at \~6 kDa and lower-M~r~LOS at \~4 kDa.](1471-2180-10-305-1){#F1}

The LOS of the wild-type human isolate *C. jejuni*520 was analysed identically (Figure [1c](#F1){ref-type="fig"}) to determine whether the temperature-related phenomenon was unique to *C. jejuni*NCTC 11168. The LOS of strain 520 was found also to separate into the two distinct forms; the higher-M~r~and lower-M~r~LOS form. The relative LOS form profile of *C. jejuni*520 was also noted to be affected by growth temperature (Figure [1b](#F1){ref-type="fig"}), whereby a slightly greater amount of the lower-M~r~LOS was produced at 42°C (lane 2).

NMR spectroscopic analysis of the higher-M~r~and lower-M~r~LOS form of *C. jejuni*111168 at 42°C
------------------------------------------------------------------------------------------------

Analysis of the OS isolated from *C. jejuni*11168-O at 37°C with 1D NMR gave spectra (data not shown) consistent with the previously published structure of *C. jejuni*NCTC 11168 \[[@B20],[@B21]\] (Figure [2](#F2){ref-type="fig"}). Given that the previous structural studies of *C. jejuni*NCTC 11168 core OS \[[@B20],[@B21]\] had been performed on bacteria grown at 37°C it was of interest to investigate the differences in the core OS structure that were observed at 42°C. To this end, bacteria were grown at 42°C, the LOS extracted and purified, and the core OS acid-liberated. Examination of the ^31^P spectrum of the OS so obtained, showed a single ^31^P peak at \~0 ppm, and which was confirmed from a heteronuclear single quantum coherence (HSQC)-total correlation spectroscopy (TOCSY) spectrum to be a phosphorylethanolamine (*P*Etn) residue. Doubling up of the anomeric line of the signal attributed substitution to the →3,4,6)-L-α-D-Hep- (**C**) which is probably due to some heterogeneity in the phosphorylation of the heptose (see Figure [2](#F2){ref-type="fig"}). Signals consistent with α-linked *N*-acetylneuraminic acid (α-Neu5Ac, sialic acid), and *N*-acetylgalactosamine (GalNAc) were also noted. Furthermore, the anomeric region of the HSQC spectrum revealed the presence of nine anomeric signals, in addition to the α-Neu5Ac. Taken together, these spectra were consistent with the previously published structure of *C. jejuni*NCTC 11168 grown at 37°C \[[@B21]\] as shown in Figure [2](#F2){ref-type="fig"}. Nevertheless, examination of the NMR spectra of another isolated minor fraction of the core OS of 11168-O grown at 42°C revealed that there was heterogeneity in the fractions with regards to the sialylation of residue (**G**). Two separate regions of the 1D ^1^H are shown in Figure [3](#F3){ref-type="fig"}; a portion of the anomeric region (5.56-5.70 ppm) and the region of the spectrum where the H3eq protons of α-Neu5Ac are expected (2.65-2.85 ppm). Spectrum 3a shows the major fraction consistent with that published in \[[@B21]\]. In spectrum 3b, the anomeric proton found at 5.67 ppm (residue **A**) is doubled up and there is a concomitant decrease in the signal intensity of H3eq protons of Neu5Ac. The anomeric resonance of **A**is distinct from the other anomeric resonances and conveniently provides a monitor of the structure of the OS in its vicinity. It is expected that the chemical shift of the anomeric resonance of **A**would be affected by differences in the sialylation of the galactose (Gal) residue (**G**). Accordingly, in the minor fraction, which has less sialylation of residue (**G**), there is the appearance of a new anomeric signal of residue **A**at 5.64 ppm.

![***C. jejuni*NCTC 11168 core OS structure**. Shown is the structure of the higher-M~r~LOS form \[[@B20],[@B21]\], the lower-M~r~form can lack the Neu5Ac residue thereby producing an asialo-GM~1~mimic. Abbreviations: Gal, galactose; GalNAc, *N-*acetylgalactosamine; Glc, glucose; Hep, heptose; Neu5Ac, *N-*acetylneuraminic acid Kdo, 3-deoxy-D-*manno*-oct-2-ulosonic acid; *P*Etn, phosphorylethanolamine.](1471-2180-10-305-2){#F2}

![**^1^H 1D spectrum (298 K, 600 MHz) of the *C. jejuni*NCTC 11168 OS**. (a) The major fraction. (b) The minor fraction. The anomeric signal of residue **A**is shown (between 5.62 - 5.70 ppm) and the H3eq proton of α-Neu5Ac (between 2.65-2.85 ppm).](1471-2180-10-305-3){#F3}

Collectively, the NMR data shows that there is a difference in sialylation between the higher-M~r~form of *C. jejuni*11168 LOS (\~6 kDa) and the lower-M~r~form (\~4 kDa); in the latter Neu5Ac can be absent, thus exhibiting asialo-GM~1~mimicry. Sialic acid is a 9-carbon sugar and has different charge properties to hexose sugars, which accounts for the approximately 2 kDa difference in apparent mass of the two LOS forms as seen in Figure [1](#F1){ref-type="fig"}.

Analysis of GM~1~epitope mimicry in *C. jejuni*LOS using cholera toxin subunit B (CTB)
--------------------------------------------------------------------------------------

*C. jejuni*11168-GS has been previously reported to mimic the structure of the GM~1~ganglioside and hence displays strong binding to CTB \[[@B20]-[@B23],[@B25]\]. Therefore, to determine whether the higher- or lower-M~r~LOS forms of *C. jejuni*11168-O and 11168-GS mimic the GM~1~epitope, the ability of both LOS forms to bind CTB was analysed using a blotting assay. The higher-M~r~LOS of *C. jejuni*11168-O and 11168-GS isolates grown at 37°C or 42°C bound CTB strongly (Figure [4](#F4){ref-type="fig"}, lanes 1-4). On the other hand, the lower-M~r~LOS did not bind to CTB, indicating that it does not exhibit GM~1~mimicry. In contrast, the higher-M~r~LOS form of *C. jejuni*strain 520 grown at 37°C or 42°C bound CTB weakly, indicating that the saccharide terminus may exhibit some ganglioside-related mimicry, though probably not GM~1~. Binding of CTB to the lower-M~r~form was not detected (Figure [4](#F4){ref-type="fig"}, lanes 5 and 6).

![**Cholera toxin blot of the LOS extracts from *C. jejuni*11168-O, 11168-GS and 520 grown at 37°C and 42°C**. Lanes: 1, 11168-O at 37°C; 2, 11168-O at 42°C; 3, 11168-GS at 37°C; 4, 11168-GS at 42°C; 5, 520 at 37°C; 6, 520 at 42°C. A control lane without blotted material did not show reactivity (not shown). Positive binding to the higher-M~r~LOS, resolved at \~6 kDa.](1471-2180-10-305-4){#F4}

Analysis of *C. jejuni*LOS epitope mimicry using peanut agglutinin (PNA)
------------------------------------------------------------------------

To further investigate the molecular mimicry of *C. jejuni*11168 LOS forms, lectin blotting was performed using PNA which binds β-D-Gal-(1→3)-D-GalNAc and β-D-Gal(1→3)-D-Gal. The disaccharide β-D-Gal-(1→3)-D-GalNAc is present as the terminal disaccharide of GM~1~ganglioside, but is also present in other gangliosides (*e.g.*asialo-GM1, GD~1~, GT~1~and GQ~1~gangliosides). PNA strongly bound both the higher-M~r~and lower-M~r~LOS forms of *C. jejuni*11168-O and 11168-GS grown at 37 and 42°C (Figure [5](#F5){ref-type="fig"}, lanes 1-4). Binding of the PNA to the higher-M~r~LOS is consistent with the presence of GM~1~-like mimicry and CTB binding observed above. Binding of PNA to the lower-M~r~LOS is also probably due to the occurrence of a terminal β-D-Gal-(1→3)-D-GalNAc in the truncated lower-M~r~LOS. Taking the results of CTB and PNA together suggests that the most likely structure for the lower-M~r~LOS form is an asialo-GM~1~-like structure.

![**PNA lectin blot of the LOS extracts from *C. jejuni*11168-O, 11168-GS and 520 grown at 37°C and 42°C**. Lanes: 1, 11168-O at 37°C; 2, 11168-O at 42°C; 3, 11168-GS at 37°C; 4, 11168-GS at 42°C; 5, 520 at 37°C; 6, 520 at 42°C. A control lane without blotted material did not show reactivity (not shown). Positive binding to higher-M~r~LOS resolved at \~6 kDa and lower-M~r~LOS at \~4 kDa.](1471-2180-10-305-5){#F5}

In contrast, both higher-M~r~and lower-M~r~LOS of *C. jejuni*520 did not bind PNA (Figure [5](#F5){ref-type="fig"}; lanes 5-6) in a similar blotting procedure. This finding was consistent with the results of CTB-binding analysis of the LOS with this strain and indicated the absence of GM~1~-like mimicry, but does not exclude other ganglioside mimicry in the LOS forms of *C. jejuni*520.

Analysis of LOS from *C. jejuni*NCTC 11168-O single colonies
------------------------------------------------------------

To determine whether the production of multiple LOS forms occurs as a result of a phase variation, LOS mini-preparations from 30 randomly selected, single colonies of *C. jejuni*11168-O grown at 37 or 42°C were analysed. Higher- and lower-M~r~LOS forms were present within each clonal population of *C. jejuni*11168-O grown at 37 or 42°C. Figure [6](#F6){ref-type="fig"} shows a representative sample of LOS profiles from single colonies grown at 42°C which showed identical profiles with \~35.5% of the total LOS produced being of 4 kDa form and \~64.5% of the 6 kDa form. LOS profiles for single *C. jejuni*11168-O colonies grown at 37°C were also identical to each other and to that shown in Figure [1b](#F1){ref-type="fig"}, lane 3 (data not shown). Equally strong binding of CTB to higher-M~r~LOS was observed for all the colonies tested suggesting that the phenomenon is unlikely to have been caused by phase variation. This was further confirmed by DNA sequence analysis of homopolymeric G- and A-tracts in *wlaN*and *cj1144-45c*genes as described below.

![**Silver-stained SDS-PAGE gel of LOS extracted from single colonies of *C. jejuni*11168-O grown at 42°C**. Lanes: 1-3, LOS from selected individual colonies. Higher-M~r~resolved at \~6 kDa and lower-M~r~LOS observed at \~4 kDa.](1471-2180-10-305-6){#F6}

The observed GM~1~mimicry of the LOS epitope was also confirmed by a colony lift whereby each of the single colonies of *C. jejuni*11168-O grown at 37°C was found to bind the GM~1~-binding ligand CTB (data not shown).

Analysis of the homopolymeric tracts from the phase variable genes *wlaN*and *cj1144-45c*in *C. jejuni*NCTC 11168-O single colonies
-----------------------------------------------------------------------------------------------------------------------------------

To further examine the nature of LOS variation in *C. jejuni*, gene expression of the homopolymeric regions of two known phase variable genes, *wlaN*(responsible for addition of terminal Gal to OS \[[@B23]\]) and *cj1144-45c*(function unknown), located in the LOS biosynthesis locus of *C. jejuni*were analysed. Both genes were amplified from 20 randomly selected single colonies of *C. jejuni*11168-O grown at 42°C and were subsequently sequenced. Each clonal population contained an 8-residue G-tract in the *wlaN*, which allows for complete translation of the gene. The sequence of *c1144-45c*was consistently found to contain a 9-residue G-tract which interrupts the reading frame. In addition, a homopolymeric A-tract of *cj1144-45c*was also examined and no sequence variation could be detected in any of the clonal populations. As further confirmation of the lack of phase variation in the *wlaN*and *cj1144-45c*genes, the total bacterial cell population from a confluent agar plate, was subjected to similar polymerase chain reaction (PCR) analysis and sequence analysis and consistently only a single sequence for each homopolymeric tract was detected. These analyses confirmed that the growth temperature did not induce sequence variation in the lengths of the homopolymeric G-tract and A-tract in *cj1144-45c*as well as in the G-tract of *wlaN*of *C. jejuni*11168-O.

LOS form variation in human and chicken isolates of *C. jejuni*
---------------------------------------------------------------

*C. jejuni*strains originally isolated from human patients and broiler chickens were examined to determine whether multiple LOS forms are common in *Campylobacter*strains (Table [1](#T1){ref-type="table"}). Figure [7a](#F7){ref-type="fig"} illustrates the diversity of the LOS forms observed in extracts from a representative selection of human and chicken isolates of *C. jejuni*from those listed in Table [1](#T1){ref-type="table"}. *C. jejuni*chicken isolates strains 331, 434, 506, 7-1 and RM1221 expressed both higher and lower-M~r~LOS forms whereas in strains 913, 019 and 008 only the higher-M~r~LOS form was detected (Table [1](#T1){ref-type="table"}). All the human isolates were found to express both higher- and lower-M~r~LOS forms except for strain 375 where only one M~r~form (higher- M~r~form) was detected (Table [1](#T1){ref-type="table"}). *C. jejuni*strains 331 (chicken), 434 (chicken), 224 (human), 421 (human) and 11168 (human) were also shown to increase the production of lower-M~r~LOS form, and a corresponding total increase in LOS production, at 42°C in contrast to 37°C (Table [1](#T1){ref-type="table"}).

###### 

Summary of the LOS phenotypes from different C. jejuni isolates.

  Origin    *C. jejuni*strain   LOS phenotype at 37°C   LOS phenotype at 42°C
  --------- ------------------- ----------------------- -----------------------
  chicken   331\*               H, L                    H, L•
            434                 H, L                    H, L•
            506\*               H, L                    H, L
            913\*               H                       H
            008                 H                       H
            019                 H                       H
            7-1                 H, L                    H, L
            RM1221              H, L                    H, L
  human     224\*               H, L                    H, L•
            291                 H, L                    H, L
            351                 H, L                    H, L
            375                 H                       H
            388                 H, L                    H, L
            421\*               H, L                    H, L•
            520                 H, L                    H, L
            11168-GS\*          H, L                    H, L•
            81116               H, L                    H, L

H, higher-M~r~LOS form

L, lower-M~r~LOS form

• Increase in the amount of LOS produced

\*Shown in Figure 7.

![**Analysis of the LOS extracts from *C. jejuni*strains of human and chicken origin grown at 37 and 42°C**. (a) Silver-stained SDS-PAGE gel. (b) CTB blot of LOS extracts resolved as in (a). Lanes: 1, 11168-O at 37°C; 2, 11168-O at 42°C; 3: 224 at 37°C; 4, *C. jejuni*224 42°C; 5, *C. jejuni*331 37°C; 6, *C. jejuni*331 42°C; 7, *C. jejuni*421 37°C; 8, *C. jejuni*421 42°C; 9, *C. jejuni*506 37°C; 10, *C. jejuni*506 42°C; 11, *C. jejuni*913 37°C; 12, *C. jejuni*913 42°C. A control lane without blotted material did not show reactivity (not shown). Positive binding of the CTB to the higher-M~r~LOS resolved at \~6 kDa.](1471-2180-10-305-7){#F7}

A CTB blot of LOS from a representative selection of human and chicken isolates of *C. jejuni*(Figure [7b](#F7){ref-type="fig"}), demonstrated the variability in LOS expression in different strains with respect to ganglioside mimicry. Only the higher-M~r~LOS form was found to bind CTB in the tested strains. Furthermore, the higher-M~r~LOS of some *C. jejuni*strains (506 and 913) did not bind CTB, indicating the absence of GM~1~ganglioside mimicry in both forms of LOS.

Discussion
==========

This study has shown that *C. jejuni*NCTC 11168-O and 11168-GS, as well as most randomly chosen chicken and human strains produce at least two distinct LOS forms when incubated at the core temperatures of human (37°C) and avian (42°C) hosts. This is consistent with previous observations that *C. jejuni*is capable of producing a variety of polysaccharide-related structures that are influenced by growth conditions, such as temperature \[[@B26]\].

Surface antigen modulation and generation of host-adapted variants are common attributes of many bacteria and enhance the pathogenicity and survivability of the microorganism, as well as the ability to evade the host immune response during the infection \[[@B27]\]. This variation may be achieved through several mechanisms, such as differential gene expression or enzymatic activity and specificity modulation, which can be triggered by a random and/or environmental stimuli \[[@B28]\]. It is possible to speculate that in the case of *C. jejuni*LOS, glycosyl transferases have the highest activity or are more stable promoting maximum functionality.

It is interesting to note that the growth temperature of *C. jejuni*NCTC 11168 was previously reported to influence the oxidative stress response \[[@B14]\]. In addition, approximately 20% of *C. jejuni*genes were reported to be up- or down-regulated in response to increasing the temperature from 37 to 42°C, including genes from the LOS and protein glycosylation clusters \[[@B15]\]. However, the change in LOS phenotype was not resolved to date.

In the present study, the phenotypic expression of the lower-M~r~LOS form appeared to be modulated by the growth temperature. This prompts speculation that the increased production of this form may be directly or indirectly caused by either specific changes in gene expression of the glycosyltransferases or glycosyl synthesis genes affecting LOS biosynthesis, thus leading to the production of varying amounts of the LOS forms. Due to the apparent loss of sialylation in the lower M~r~LOS structure it is likely that the variation of the structure is attributable to functional differences in the synthesis of the transport machinery of sialic acid under the different temperatures. We consider the most likely candidate for this difference to be the dual functioning enzyme, GalNAc transferase and CMP-Neu5Ac synthase, CgtA \[[@B18]\].

It is also tempting to speculate that the increased production of the lower-M~r~LOS form at 42°C might play a role in the bacterial-host interactions of *C. jejuni*. The increased production of the 4 kDa form which occurred at 42°C, the avian host body temperature, raises a possibility that this form could contribute to the commensalism by this bacterium in poultry \[[@B17]\]. The increase at 37°C in the proportion of the higher M~r~LOS, the portion of the LOS that is sialylated and is a GM~1~mimic \[[@B20],[@B21]\], indicates an increase in the production of an LOS structure that is thought to have a role in immune evasion and survival in mammalian hosts \[[@B29]\]. These hypotheses, however, will require further investigation, particularly chicken and murine infection studies.

Phase variation is the most commonly described mechanism, for antigenic variation and changes in the phenotype of the microorganism. Like *Neisseria meningitidis*and *Haemophilus influenzae*, *C. jejuni*is also known to exhibit modulation of its surface polysaccharide structures as a result of phase variation \[[@B27],[@B30]\]; however, this does not appear to be the case with production of the temperature-related LOS form in *C. jejuni*. Both forms were consistently produced by all clonal populations of *C. jejuni*11168-O examined in this study suggesting that modulation of LOS forms is unlikely to be caused by phase variation. Furthermore, we have analyzed the \"on-off\" status of phase variable genes (*wlaN*and *cj1144-45c*) in *C. jejuni*LOS biosynthesis cluster to further demonstrate that the described variation of LOS forms is not being caused by phase variation of LOS genes. *C. jejuni*11168-O grown at 42°C was used in this experiment as it shows greater abundance of the lower-M~r~LOS form, hence increasing the chance of detecting changes in phase variable genes. Lengths of the homopolymeric G and A tracts from *wlaN*and *cj1144-45c*genes did not vary in any of 20 randomly selected colonies, suggesting that these genes are under regulatory mechanisms unaffected by growth temperature and the described variation of LOS forms is not caused by variation in the lengths of the homopolymeric tracts. Furthermore, no change in the GM~1~mimicry of the clonal populations had been observed. It is also interesting to note that not all strains of *C. jejuni*expressed multiple LOS forms irrespective of the isolation origin, human or chicken.

No differences were observed in the production of the various LOS forms between the two variants of 11168, the genome sequenced and original isolate. The higher-M~r~form of *C. jejuni*11168 (\~6 kDa) exhibited GM~1~-like mimicry and, therefore, corresponded to the previously characterized LOS \[[@B20],[@B21],[@B23]\]. Studies with CTB, a well-known binder of GM~1~ganglisoide \[[@B25]\], confirmed the presence of a GM~1~mimic in this form of NCTC 11168. Similar mimicry was also detected among the higher-M~r~LOS forms of the other isolates of humans and chickens tested, but not in the lower-M~r~form of any other strains. The weak binding of CTB to the higher-M~r~LOS variant of *C. jejuni*520 reflects that the saccharide terminus may exhibit some ganglioside-related mimic, though not GM~1~mimicry. This is shown by the CTB binding to ganglioside-related structures not just GM~1~and PNA did not confirm the presence of a terminal β-D-Gal-(1→3)-D-GalNAc. A CTB binding affinity study showed that the lower-M~r~form of *C. jejuni*NCTC 11168 failed to bind to the lectin. Nevertheless, the results of the present study showed that it contains a β-D-Gal-(1→3)-D-GalNAc disaccharide moiety in the core consistent with production of a truncated (because of its lower molecular mass), but related form, of the NCTC 11168 structure previously described \[[@B21]\], and is an asialo-GM~1~-like structure.

Conclusion
==========

In conclusion, this study identified the presence of a lower-M~r~LOS form produced by *C. jejuni*NCTC 11168 and other clinical and avian strains. The lower-M~r~form production was growth-temperature related as higher quantities were observed at 42°C. It is tempting to speculate that the occurrence of greater quantities of this form at avian body temperature might play a role in an adaptative mechanism to aid commensal colonization of such hosts. Alternatively, changes in the relative production of the two forms of LOS at the higher temperature could be related to a stress response. Such a phenomenon has already been seen with increased oxygen tension in the growth atmosphere of *C. jejuni*influencing the structural mimicry exhibited in the LOS of this bacterium \[[@B31]\]. Although an intriguing phenomenon, further investigations are required to evaluate these alternate hypotheses.

Methods
=======

Bacterial strains and growth conditions
---------------------------------------

The original isolate of *C. jejuni*NCTC 11168 (11168-O) that had been characterized by Gaynor *et al.*(2004) \[[@B17]\], *C. jejuni*11168-GS (genome-sequenced NCTC 11168) that had been sequenced and annotated at the Sanger Centre (Hinxton, Cambridge, UK) \[[@B16]\], and strain 81116 were kindly supplied by D.J. Newell (Veterinary Laboratories Agency, Weybridge, UK). *C. jejuni*RM1221 has been described \[[@B32]\] and was kindly provided by R. E. Mandrell (United States Department of Agriculture, CA, USA.). *C. jejuni*clinical isolates 224, 291, 351, 375, 388, 421, 520, and chicken isolates 008, 019, 331, 434, 506, 913, 7-1 were obtained from the Royal Melbourne Institute of Technology (Melbourne, Vic., Australia) and Griffith University (Gold Coast, Qld., Australia) culture collections. All *C. jejuni*strains were subcultured no more than once to avoid the influence of passaging. Strains were grown on blood agar, composed of Columbia agar containing 5% (v/v) defibrinated horse blood and Skirrow\'s antibiotic supplement (Oxoid), under microaerobic conditions (5% O~2~, 10% CO~2~and 85% N~2~) at 37°C for 48 h and 42°C for 24 h.

LOS preparations
----------------

### For gel electrophoresis

Blood agar-grown bacteria were harvested in 1 mL of sterile water, washed once in 1 mL of sterile water, and lysed by heating. Prior to lysis, samples were adjusted for numbers of bacteria using the OD~600~measurements of bacterial suspensions. Mini-preparations of LOS were prepared by treating the whole-cell extracts with proteinase K as described previously \[[@B33]\]. The LOS mini-preparations from single colonies were prepared by collecting and washing cells in 40 μL of sterile water and then lysing by heating. Purified *C. jejuni*LOS was prepared by subjecting the biomass to hot phenol-water treatment using 90% (v/v) aqueous phenol at 65°C for 10 min \[[@B34]\]. Extracted LOS was purified by enzymatic treatment as described previously \[[@B19]\]. The LOS preparations were made up to 15 μg/μL in distilled water prior to gel electrophoresis.

### For NMR analysis

*C. jejuni*11168 was grown for 24 hr as described above and bacterial biomass was harvested and washed twice using phosphate-buffered saline pH 7.4 (PBS; Sigma) and centrifugation (5000 × *g*, 4°C, 15 min). Biomass was lyophilised and 21 g and 20 g dry-cell mass was collected from cultures grown at 37°C and 42°C, respectively. Dried biomass was pretreated using pronase-E \[[@B35]\]. Extraction of LOS was carried out using hot-phenol water technique \[[@B34]\]. Water-soluble LOS was purified using RNaseA, DNase II and proteinase K (Sigma) and ultra-centrifugation, as previously described \[[@B19]\]. The LOS were treated with 0.1 M HCl at 100°C for 2 hours to cleave the acid-labile ketosidic linkage between the core OS and lipid A \[[@B19]\]. The lipid A precipitate was removed by centrifugation (5000 × *g*, 4°C, 30 mins), washed and both this and supernatant were lyophilised. The supernatant was fractionated using gel-permeation chromatography on a column of Bio-Gel P4 (1 m × 2 cm) with 0.05 M pyridinium acetate (pH 4.5) as the eluent. The resultant fractions were monitored by capillary-tube spotting on silica gel 60 TLC plates (Merck), followed by charring with 20% H~2~SO~4~in EtOH at 150°C. The water-soluble carbohydrate-containing fractions of core OS were flash-frozen in dry-ice/acetone bath and lyophilized.

CPS and whole-cell protein preparations
---------------------------------------

For assessing CPS production, proteinase K-treated whole cell extracts were prepared as described above. Whole-cell protein samples were prepared by incubating SDS-PAGE loading buffer with *C. jejuni*biomass at 100°C for 5 min to facilitate bacterial lysis and binding of the SDS to the denatured proteins.

Electrophoretic analyses
------------------------

Equal quantities of samples, either LOS mini-preparations or purified LOS, and CPS samples were resolved on 10% (v/v) SDS-PAGE containing urea (6 M) and tricine (0.3 mM) (Tricine-SDS-PAGE) with tricine-containing cathode buffer as previously described \[[@B36]\]. Stacking and separating gels contained 5.5% and 10% (v/v) acrylamide, respectively. Following the electrophoresis of LOS samples, gels were fixed and the resolved molecules were detected using the carbohydrate silver staining method \[[@B37]\] or CPS by Alcian Blue staining \[[@B38]\]. Electrophoresis was conducted at 30 V for 1 h to maximize stacking and then separated at 200 V for 30 min. Whole-cell protein samples were resolved on glycine-buffered 15% (v/v) polyacrylamide gels (Glycine-SDS-PAGE) as previously described \[[@B39]\]. Electrophoresis was conducted at 100 V for 1.5 h. Proteins were detected by conventional Coomassie Blue staining \[[@B19]\]. Densitometry image analysis was performed using the QuantityOne software package (Bio-Rad). The published *M. catarrhalis*LOS from *M. catarrhalis*wild-type (strain 2951) and the *lgt4*LOS biosynthesis mutant \[[@B24]\] were used as a control for relative size determination of LOS structures due to the loss of a single hexose sugar from the known OS structure.

NMR spectroscopy
----------------

Purified OSs were dissolved in D~2~O (CIL 99.998%) and cycled through 3 steps of lyophilization/dissolution to remove exchangeable protons. ^1^H and ^13^C NMR experiments were performed at 600 MHz and 150 MHz respectively at 298 K or 278 K in D~2~O using a Bruker Avance spectrometer. Chemical shifts are reported in ppm referenced to DSS. Spectral assignment was aided by recording of ^1^H 1D, gradient correlation spectroscopy (COSY), TOCSY, (60 and 120 ms mixing time), ^13^C attached proton test (APT), ^1^H-^13^C-HSQC and edited ^1^H-^13^C-HSQC (CH and CH~2~correlations opposite sign), ^1^H-^13^C-HSQC-TOCSY and edited ^1^H-^13^C-HSQC-TOCSY (60 and 120 ms mixing time) (one bond C-H correlations opposite sign), and ^1^H-^13^C-HSQC-nuclear Overhauser enhancer spectroscopy (-NOESY), NOESY (400 ms) spectra. In addition, 1D selective TOCSY experiments were used to assist with the assignment process. All spectra were acquired using unmodified pulse sequences from the Bruker pulse sequence library.

Ligand and Western blotting
---------------------------

In addition to chemical staining, the fractionated *C. jejuni*LOS was transferred from Tricine SDS-PAGE gels onto a Pall^®^PVDF membrane using a semi-dry transblotter (Bio-Rad). After transfer, the membrane was reacted with horseradish peroxidase-(HRP-) conjugated CTB (3 μg mL^-1^), or with HRP-conjugated PNA (lectin from *Arachis hypogaea*) (5 μg mL^-1^), or with HRP-conjugated anti-GM~1~ganglioside IgG (diluted 1:3000) in PBS. Membranes were developed using HRP Color Development Solution (Bio-Rad) or SuperSignal HRP Chemiluminescent Substrate (Thermo Scientific) according to the manufacturer\'s instructions.

Colony lift
-----------

*C. jejuni*was grown on Columbia agar containing 2% (v/v) horse blood under microaerobic conditions as described above. The lower concentration of blood was used to reduce the background during the blotting procedure. Colonies were bound to the nitrocellulose membrane by overlaying the agar plate. The membrane was then baked for 1 h at 80°C as described elsewhere \[[@B40]\]. Subsequently, the membrane was blotted with HRP-CTB as described above.

Amplification and sequencing of phase variable genes *wlaN*and *cj1144-45c*
---------------------------------------------------------------------------

For PCR *wlaN*G-tract forward (GATATAGCTAAAGAGTATGCTAGTAAAG) *wlaN*G-tract reverse (GGATAATATAATAAGGCATCTTCTGCC) and *cj1144-45c*G-tract forward (GGGTTGATGAAGCAAGAAATTAGTAG) *cj1144-45c*G-tract reverse (GCTAAAAACCAAGGTCCTATAACACC) primer combinations wee used. Twenty (20) reactions were inoculated with bacteria from single colonies of *C. jejuni*11168-O grown at 42°C. Amplified \~500 bp fragments were cleaned up using an Eppendrof Perfectprep Gel Cleanup kit and were sent for sequencing at the Australian Genome Research Facility (University of Queensland, St. Lucia, Brisbane, QLD, Australia).
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